SS

Sangamma Shreekant Patil

Active Director Designated Partner DIN 10523487
DIN 10523487 First appointment Feb 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangamma Shreekant Patil

Data last updated:

Sangamma Shreekant Patil is a Designated Partner at Dr. Shrikant Patil Multi-Speciality Hospital Llp (since 2024).

DIN 10523487
Primary Designation Designated Partner
First Appointment 26 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Feb 20242024Active

Board colleagues of Sangamma Shreekant Patil

NameDINCompanyDesignation
Shrikant Parmeshwar Patil10523486Dr. Shrikant Patil Multi-Speciality Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dr. Shrikant Patil Multi-Speciality Hospital Llp
Premium access

Shareholding and investment profile for Sangamma Shreekant Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangamma Shreekant Patil

Sangamma Shreekant Patil currently holds 1 directorship: Dr. Shrikant Patil Multi-Speciality Hospital Llp (Designated Partner, since 26 Feb 2024).

Sangamma Shreekant Patil was first appointed on 26 Feb 2024 as Designated Partner at Dr. Shrikant Patil Multi-Speciality Hospital Llp.

The current boards of Sangamma Shreekant Patil's companies include Shrikant Parmeshwar Patil (Dr. Shrikant Patil Multi-Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available